SMS Pharmaceuticals consolidated net profit rises 76.45% in the June 2024 quarter
Net profit of SMS Pharmaceuticals rose 76.45% to Rs 16.48 crore in the quarter ended June 2024 as against Rs 9.34 crore during the previous quarter ended June 2023. Sales rose 21.51% to Rs 164.45 crore in the quarter ended June 2024 as against Rs 135.34 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 164.45 | 135.34 | 22 |
OPM % | 20.38 | 19.35 | - |
PBDT | 30.21 | 20.37 | 48 |
PBT | 21.83 | 12.68 | 72 |
NP | 16.48 | 9.34 | 76 |
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FStocks_258031f448%2FStocks_258031f448.png&w=256&q=75)
Low Price Shares
0 mins read . Dec 18, 2024
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FBest_Stocks_Under_10_Rupees_in_India_be7ded3097%2FBest_Stocks_Under_10_Rupees_in_India_be7ded3097.webp&w=256&q=75)
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FBest_Stocks_Under_100_in_India_2024_ef4b01fbcf%2FBest_Stocks_Under_100_in_India_2024_ef4b01fbcf.jpg&w=256&q=75)
Best Stocks in 2025
0 mins read . Dec 18, 2024
![future contract](/_next/image?url=%2Fnxt_assets%2FMask%20group.png&w=640&q=75)
Explore our products
Unlimited Trading starting at ₹249
Open Trading Account